MyAverix Finance
TWO · Healthcare
Medigen Biotechnology (3176)
Biotechnology
Medigen Biotechnology (3176) is listed on TWO in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 3176
Medigen Biotechnology (3176) — FAQ
What is 3176's P/E ratio?
The price-to-earnings (P/E) ratio for Medigen Biotechnology (3176) is 25.00 (data as of 2026-05-23).
Does Medigen Biotechnology pay a dividend?
Dividend yield is not available in the current snapshot for Medigen Biotechnology (3176). Check the MyAverix Finance app for the latest dividend data.
What sector is Medigen Biotechnology in?
Medigen Biotechnology (3176) is classified in the Healthcare sector (Biotechnology industry).
What exchange is 3176 listed on?
3176 is listed on TWO.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.